Medpace Holdings Inc
For the period ended Jun 30, 2024. Filed Jul 23, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 23, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended June 30, 2024, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
-26-
| Action | Date | Trading Arrangement | Total Shares to be Purchased or Sold | Duration/Expiration Date | ||
| Rule 10b5-1* | Non-Rule 10b5-1** | |||||
|---|---|---|---|---|---|---|
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Adopt | April 25, 2024 [1] | X | Up to 190,000 shares to be sold | Good until cancelled | |
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Modify | May 22, 2024 [2] | X | Up to 190,000 shares to be sold | Good until cancelled | |
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Terminate | May 30, 2024 [3] | X | Up to 190,000 shares to be sold | Good until cancelled | |
| Susan E. Burwig, Executive Vice President, Operations | Adopt | June 5, 2024 [4] | X | Up to 7,681 shares to be sold | The earlier of until cancelled or 180 days from the placement of the limit order | |
- Intended to satisfy the affirmative defense of Rule 10b5-1(c).
** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
[1] On April 25, 2024, August J. Troendle placed a limit order to sell up to 190,000 shares that were previously acquired through various stock option exercises. Between April 25, 2024 and May 21, 2024, Mr. Troendle sold 142,250 shares pursuant to the limit order.
[2] On May 22, 2024, August J. Troendle changed the price limit for sales under the limit order originally adopted on April 25, 2024.
[3] On May 30, 2024, August J. Troendle terminated the limit order originally adopted on April 25, 2024.
[4] On June 5, 2024, Ms. Burwig placed a limit order to sell up to 7,681 shares that were acquired upon the vesting of restricted shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.